The Clinical Features and Prognosis of Gastric Remnant Carcinoma after Treatment

Hepatogastroenterology. 2014 May;61(131):587-9.

Abstract

Background/aims: The incidence of gastric remnant carcinoma does not decrease after partial gastrectomy The aim of this study was to evaluate the clinical features and prognosis of gastric remnant carcinoma after treatment.

Methodology: Among 412 gastric carcinoma patients who were admitted to our hospital 21 were found to have gastric remnant carcinoma. We analyzed their clinicopathological features and prognosis.

Results: Prognosis did not differ significantly in terms of gender, age, tumor-lymph node-metastasis stage, tumor location, and time interval between first and subsequent operations. However, it was influenced by intensive curative gastrectomy with or without resection of local lymph nodes.

Conclusion: Long-term follow-up after gastrectomy, appropriate curative resection, as well as prevention and management of hypertensive disease co-mobility are important to improve survival rate of gastric remnant carcinoma operation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Carcinoma / mortality
  • Carcinoma / pathology
  • Carcinoma / surgery*
  • Chemotherapy, Adjuvant
  • Comorbidity
  • Female
  • Gastrectomy* / adverse effects
  • Gastrectomy* / mortality
  • Gastric Stump / pathology
  • Gastric Stump / surgery*
  • Humans
  • Hypertension / epidemiology
  • Hypertension / therapy
  • Lymph Node Excision
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Reoperation
  • Risk Factors
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery*
  • Stomach Ulcer / surgery*
  • Survival Analysis
  • Time Factors
  • Treatment Outcome